As of January 22, 2025, Applied Therapeutics (APLT) has a market cap of $73.118 million USD. According to our data, Applied Therapeutics is ranked No.7928 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $73.12 M |
-26.59%
|
Dec 31, 2024 | $99.60 M |
-74.45%
|
Dec 29, 2023 | $0.39 B |
340.79%
|
Dec 30, 2022 | $88.43 M |
-91.51%
|
Dec 31, 2021 | $1.04 B |
-59.34%
|
Dec 31, 2020 | $2.56 B |
-19.32%
|
Dec 31, 2019 | $3.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Abeona Therapeutics
ABEO
|
$0.22 B |
0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Market Cap | = | APLT Stock Price | * | APLT Shares Outstanding |
= | $0.63 | * | 0.12 B | |
= | $73.12 M |